What can be done to prevent graft versus host disease?
Graft versus host disease presents a major obstacle to the widespread application of allogeneic bone marrow transplantation despite improvements in drug prophylaxis. Although animal models are providing an understanding of the biology of the process, opportunities for exploitation of that knowledge...
Main Authors: | Waldmann, H, Cobbold, S, Hale, G |
---|---|
Format: | Journal article |
Language: | English |
Published: |
1994
|
Similar Items
-
Monoclonal antibodies for the prevention of graft-versus-host disease and marrow graft rejection. The depletion of T cell subsets in vitro and in vivo.
by: Cobbold, S, et al.
Published: (1986) -
CAMPATH-1 FOR PREVENTION OF GRAFT-VERSUS-HOST DISEASE AND GRAFT-REJECTION - SUMMARY OF RESULTS FROM A MULTI-CENTRE STUDY
by: Hale, G, et al.
Published: (1988) -
T-CELL DEPLETION BY EXPOSURE TO CAMPATH-1G IN-VITRO PREVENTS GRAFT-VERSUS-HOST DISEASE
by: Jacobs, P, et al.
Published: (1994) -
T cell depletion by exposure to Campath-1G in vitro prevents graft-versus-host disease.
by: Jacobs, P, et al.
Published: (1994) -
T-cell depletion of bone marrow grafts with Campath 1 ex vivo prevents graft-versus-host disease without abrogating the antileukaemic effect of transplantation
by: Novitzky, N, et al.
Published: (1997)